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Background: This study examined (1) the factor structure of a depressive symptoms scale (DSS), (2) the sex and
longitudinal invariance of the DSS, and (3) the predictive validity of the DSS scale during adolescence in terms of
predicting depression and anxiety symptoms in early adulthood.
Methods: Data were drawn from the Nicotine Dependence in Teens (NDIT) study, an ongoing prospective cohort
study of 1,293 adolescents.
Results: The analytical sample included 527 participants who provided complete data or had minimal missing data over
follow-up. Confirmatory factor analysis revealed that an intercorrelated three-factor model with somatic, depressive, and
anxiety factors provided the best fit. Further, this model was invariant across sex and time. Finally, DSS scores at Time 3
correlated significantly with depressive and anxiety symptoms measured at Time 4.
Conclusions: Results suggest that the DSS is multidimensional and that it is a suitable instrument to examine sex
differences in somatic, depressive, and anxiety symptoms, as well as changes in these symptoms over time in adolescents.
In addition, it could be used to identify individuals at-risk of psychopathology during early adulthood.
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The prevalence of major depression in North American ad-
olescents 12 to 18 years of age ranges from 6% to 9% [1].
An even higher proportion experience depressive symp-
toms without meeting formal criteria for clinical diagnosis
[2]. Sub-threshold depression during adolescence has been
linked to major depression disorder (MDD) in adulthood
[3,4]. In addition, adolescents who report higher levels of
depressive symptoms report lower levels of well-being, self-
esteem, physical health, and educational performance [3,5].
To facilitate investigation of the causes and conse-
quences of sub-threshold depression, measures of depres-
sive symptoms have been developed. Kandel and Davies
[6] developed a 6-item depressive symptoms scale (DSS)
to rapidly assess depressive symptoms, which has been
used in a number of studies with adolescents e.g., [7-9]. It
is based on the depressive mood subscale of the Hopkins* Correspondence: jennifer.brunet@uottawa.ca
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reproduction in any medium, provided the orSymptom Checklist SCL-90 [10], and the reliability and
validity of the scores have been supported in adolescent
populations [6,7,11,12]. However, only two studies to date
have reported on its factor structure. Kandel and Davies
[6] first tested the factor structure in a small clinical sam-
ple (n = 29) of adolescents and concluded that the scale
was unidimensional. This finding was supported in a lar-
ger sample of secondary school students [13], but the re-
sults of the factor analysis were not reported and the
authors did not test alternative models in this study. Al-
though these two studies suggest that the DSS is unidi-
mensional, Costello and Angold [14] suggested that the
items that comprise the scale assess anxiety and somatic
symptoms in addition to depressive symptoms. Specifically,
the items assessing feelings of nervousness and worry are
characteristic of anxiety, the items assessing feelings of fa-
tigue and insomnia are characteristic of somatic symptoms
of both depression and anxiety, and the items assessing
feelings of sadness and hopelessness are characteristics of
depression [15]. Therefore, alternative factor structures of
the DSS should be tested.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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depression and anxiety are distinct constructs [16,17], or
whether they are two facets of a single syndrome since
they often co-occur and there is overlap in their symptoms
[18]. Clark and Watson [19] developed the tripartite
model which has been supported in youth populations
[17], which posits that the affective dimensions of distress
can be conceptualized as either general affective distress
or as two specific factors (i.e., depression and anxiety). In
addition to conceptual uncertainty, factor-analytic studies
of other measures that claim to assess depressive symp-
toms raise questions about the dimensionality of the DSS.
In particular, varying factor structures have been reported
for other self-report measures including the Hospital Anx-
iety and Depression Rating Scale (HADS) [20], the Beck
Depression Inventory – Second Edition (BDI-II) [21], the
Center for Epidemiological Studies Depression scale
(CES-D) [22], and the Reynolds Adolescent Depression
Scale (RADS) [23]. For example, researchers have found
support for both a two-factor model and a three-factor
model for the HADS [24,25] and the BDI-II [26,27].
Others report evidence for a four-factor model for the
CES-D [28,29]. Based on these conceptual and methodo-
logical perspectives, it is possible that the DSS may be best
conceptualized as multidimensional, with three related
factors (i.e., somatic, depressive, and anxiety symptoms).
As well, considering that it can be difficult to determine if
somatic complaints are expressions of psychological dis-
tress as they may be attributed to biological and hormonal
changes associated with puberty (e.g., hormonal fluctua-
tions during menstrual cycles can cause fatigue, growth
spurts can bring changes in appetite), and that somatic
symptoms during adolescence have been shown to predict
depression and other mental disorders during adulthood
[30], it may be appropriate to distinguish between somatic
and affective symptoms in a two-factor model.
In addition, although other measures of depression have
been shown to possess evidence of sex and longitudinal in-
variance e.g., [28,29], evidence for the measurement invari-
ance for the DSS are lacking since such tests have yet to be
conducted. Invariance refers to the extent to which scores
on a measure hold equivalent meaning across groups or
conditions [31]. Given that other self-report measures of
depression have been found to be non-invariant across sex
[32,33] and that differences in depressive symptoms by
sex and over time are of interest to researchers e.g.,
[11,34], conducting invariance testing with the DSS is
critical. If shown to be invariant, reported differences in
levels of depressive symptoms across these characteris-
tics can be interpreted as true differences rather than
measurement artifact [35].
Finally, demonstrating that the DSS predicts future
psychopathology has important practical implications
because depressive symptoms during adolescence havebeen linked to MDD and anxiety in adulthood [3,4]. Specif-
ically, the scale could be used to identify which individuals
should be targeted for intervention during adolescence to
prevent future MDD. Kandel and Davies [13] showed that
levels of depressive symptoms assessed during adolescence
were significantly associated with depressive symptoms in
young adulthood. However, evidence regarding the predict-
ive validity of the DSS is limited to this study and only
using a global DSS score. If the factor structure of this
measure is multidimensional, it will be important to deter-
mine whether the different subscales allow researchers to
predict future mental health. Adolescents in community
samples who are diagnosed with an anxiety disorder can
develop depression, while a smaller proportion of those di-
agnosed with depression later develop anxiety [36,37].
Therefore, the specific subscales of the DSS may be more
accurate (i.e., valid and reliable) predictors of future specific
psychopathological symptoms than a global symptoms
scores, and thus the probability of accurately identifying
adolescents at risk of developing specific psychopatho-
logical symptoms may be increased. This highlights the
need to examine the predictive validity of the multidimen-
sional factor structure if this conceptualization holds and is
shown to be superior to a unidimensional factor structure.
The current investigation had three objectives. The first
objective was to test the factor structure of the DSS in a
large, non-clinical sample of adolescents by comparing a
single-factor, an intercorrelated two-factor, and an inter-
correlated three-factor model. Based on a content review
of the scale, reports that the scale may be multidimen-
sional [14], and theoretical postulations about how anxiety
and depression may interrelate [19], it was hypothesized
that an intercorrelated three-factor model would demon-
strate the best fit. The second objective was to examine
sex and longitudinal invariance of the measurement pa-
rameters for the best fitting model. It was hypothesized
that the measure would demonstrate sex and longitudinal
invariance. The third objective was to test the validity of
the DSS (or DSS subscales) in predicting future depression
and anxiety. It was hypothesized that the scale (or sub-
scales) assessed during adolescence would show significant
associations of moderate magnitude with depression and
anxiety disorders assessed during young adulthood.
Methods
Procedures and participants
Data were drawn from the Natural History of Nicotine
Dependence in Teens (NDIT) study, a longitudinal cohort
investigation of 1,293 adolescents who were 12-13 years at
baseline [38]. The NDIT study was designed to investigate
the natural course of nicotine dependence, as well as iden-
tify genetic, sociodemographic, psychosocial, and environ-
mental risk factors for the onset of smoking and nicotine
dependence. Data were also collected on health behaviors
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blood pressure were collected at baseline and biannually
thereafter to allow for the investigation of other risk fac-
tors for cancer and cardiovascular disease. Participants
were recruited from all grade 7 classes in a convenience
sample of 10 secondary schools in Montreal, Quebec, se-
lected to represent a range of socioeconomic status (low,
medium, high), geographic locations (urban, suburban,
rural), and languages [French (n = 3), English (n = 7)].
French or English questionnaires were administered ac-
cording to the language used in each study school. If
questionnaire items were already available in French,
these items were used. If the items were not available in
French, they were translated by two Francophone phy-
sicians, back-translated to test the accuracy of the
translation, and then pilot tested in the target group for
readability and ease of comprehension. The study received
approval from the McGill University Institutional Review
Board and the Centre de Recherche du Centre Hospitalier
de l’Université de Montréal. Participants provided assent
and a parent/guardian provided written informed consent.
The baseline questionnaire was administered in the fall
of 1999. The interval between each subsequent survey
cycle was 3-4 months, resulting in 20 survey cycles over
the five years during secondary school. At each of these 20
survey cycles, participants completed a self-administered
questionnaire during regular class time. An additional data
collection took place in 2007-2008 (survey cycle 21), when
participants were aged 18-24 years, using mailed self-
report questionnaires. Data from survey cycles 1 (Time 1),
10 (Time 2), 19 (Time 3), and 21 (Time 4) were used in
the current analyses when the mean (SD) ages of partici-
pants were 12.6 (0.4), 14.9 (0.4), 17.1 (0.4), and 20.2 (0.6)
years, respectively.
The sample for the analyses involving Time 1, 2, and 3
(used to address objectives 1 and 2) comprised 527 par-
ticipants (46.3% boys) who provided complete data or
had less than 20% of their data missing by design or at
random at each of Time 1, 2, and 3. This sample was re-
duced to 426 participants (44.9% boys) for the analyses
involving Time 4 (used to address objective 3) due to at-
trition. No statistically significant differences were ob-
served in baseline depressive symptoms scores (F = 2.24,
df = 1, p > 0.05) or sex (χ2 = 1.38, df = 1, p > 0.05) between
adolescents included and not included in the analyses.
Also, the percentage of mothers (48.3% vs. 41.9%, χ2 =
3.77, df = 1, p > 0.05) and fathers (48.5% vs. 44.0%, χ2 =
1.75, df = 1, p > 0.05) who attended university did not dif-
fer significantly between the retained and not-retained
groups. However, participants included in the analyses were
younger (mean = 12.1, SD = 0.7 vs. mean = 12.4, SD = 0.4;
F = 70.54, df = 1, p < 0.001), and more likely to have com-
pleted the questionnaire in English (75.1% vs. 57.1%, χ2 =
42.40, df = 1, p < 0.05), than participants excluded from theanalyses. Data on ethnicity collected at Time 4 indicated
that 77.5% of participants self-identified as White.
Measures
Participants completed the 6-item DSS [6] at Time 1, 2,
and 3. Participants were asked to indicate the degree to
which they (1) “felt too tired to do things”, (2) “had trouble
going to sleep or staying asleep”, (3) “felt unhappy, sad, or
depressed”, (4) “felt hopeless about the future”, (5) “felt
nervous or tense”, and (6) “worried too much about
things.” Participants responded to each item using a 4-
point Likert scale (modified from the original 3-point
scale) ranging from 1 (“never”) to 4 (“often”). Because of
the NDIT study design, the recall period was the past 3
months. Researchers have reported test–retest reliability
(intraclass correlation coefficients; ICC) > 0.76, internal
consistency coefficients (Cronbach’s α) > 0.72, and face
validity for the DSS in previous studies with adolescent
populations [6,7]. Also, the correlation coefficient (Pearson
r = 0.72) previously reported between DSS scores and
scores on the depression subscale of the SCL-90 in a clin-
ical sample of youth 14-16 years of age provides support
for the concurrent validity of this scale [6].
The Major Depression Inventory (MDI) [39] was used
in survey cycle 21 (Time 4) to assess depressive symptoms.
Participants were asked to self-report the frequency with
which they experienced 12 symptoms (e.g., “felt that life
wasn’t worth living”, “suffered from reduced appetite”) in
the past 14 days using a 6-point response scale ranging
from 0 (“at no time”) to 6 (“all the time”). A total MDI
score was calculated and symptom-specific subscale scores
were calculated for somatic symptoms and affective/cogni-
tive symptoms, with higher scores indicating more fre-
quent depressive symptoms. Scores on the MDI have been
shown to be valid and reliable in adults [40,41].
Lifetime presence of symptoms of panic disorder, social
phobia, agoraphobia, and generalized anxiety disorder was
assessed at Time 4. Participants indicated whether they
had ever experienced each symptom by indicating 1 (“no”)
or 2 (“yes”). Panic disorder symptoms were present if par-
ticipants responded “yes” to experiencing “an attack of fear
or panic when all of a sudden you felt very frightened,
anxious or uneasy” and/or “an attack when all of a sudden,
you became dizzy, very uncomfortable, short of breath,
dizzy, nauseous, your heart pounded, or you thought that
you might lose control, die or go crazy.” Social phobia dis-
order symptoms were present if participants responded
“yes” to experiencing “a time when you felt very afraid or
really shy meeting new people, going to parties, going on a
date” and/or “a time when you felt very afraid or uncom-
fortable when you had to do something in front of a group
of people (giving a speech, speaking in class).” Agoraphobia
disorder symptoms were present if participants responded
“yes” to experiencing “a time in your life when you felt
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alone” and/or “a time in your life when you became very
upset or nervous in crowds, public places, or traveling.”
Generalized anxiety disorder symptoms were present if par-
ticipants responded “yes” to experiencing “a time when you
were a “worrier” (when you worried a lot more about things
than other people with the same problems)” and/or “a time
when you were much more nervous or anxious than most
other people with the same problems.” An additional anx-
iety variable was created whereby participants who reported
at least one of the above anxiety disorder symptoms were
coded as yes for ‘presence of anxiety’.
Questions on anxiety screening in survey cycle 21 (Time
4) were based on the Canadian Community Health Survey
(CCHS; Cycle 1.2) [42]. The CCHS interview is based on
the World Mental Health Survey Initiative Version of the
World Health Organization (WHO) Composite Inter-
national Diagnostic Interview (CIDI) [43]. While the CCHS
and the CIDI are interviewer-administered, the NDIT ques-
tionnaire was self-administered since the interviewer-
administered format was neither feasible nor desirable since
social desirability bias is lower with the self-administered
than interviewer-administered version [44]. Further, there is
acceptable agreement between the self- and interviewer-
administered versions of the CIDI [45,46]. Of note, the
question wording and instructions, response categories, for-
matting, question order, and response categories of the
interviewer-administered CCHS were preserved.
Data analysis
Factor structure
Multiple imputation expectation-maximization algorithm
[47] was used to estimate and replace missing observa-
tions when data loss on the DSS was minimal (i.e., 0.2%-
2.3%). The factor structure of the DSS was tested at each
time point using confirmatory factor analysis (CFA) with
robust maximum likelihood estimation in LISREL (version
8.80) following recommended procedures [35]. Owing to
the ordered-categorical nature of the data, the Satorra-
Bentler scale chi-square statistic and robust standard er-
rors were used since they yield unbiased goodness-of-fit
indices when dealing with non-normal data. Three models
were tested: (i) a single-factor structure where all items on
the DSS were specified to represent one latent variable
termed generalized distress, (ii) a two-factor intercorre-
lated structure where the items represent two latent vari-
able: somatic symptoms and generalized affective distress,
and (iii) a three-factor intercorrelated structure where the
items represent three latent variables: somatic symptoms,
depressive symptoms, and anxiety symptoms. Table 1 pre-
sents the items corresponding to the latent variables in
each model. The factor loading for the first item of each
latent variable was set to 1.0 to establish the metric of the
latent variable.Based on recommendations by Chen [48] for compar-
ing nested models, the single-factor, intercorrelated two-
factor, and intercorrelated three-factor models were
compared at each time point by examining change in
Comparative Fit Index (CFI) and Root Mean Square
Error of Approximation (RMSEA) values (ΔCFI ≤ 0.010
combined with ΔRMSEA ≤ 0.015 indicates no significant
differences between models), as well as observation of mul-
tiple robust indices [49], namely the CFI, RMSEA, and Stan-
dardized Root Mean Square of the Residuals (SRMR)
values. Values of 0.90 and higher for the CFI indicate accept-
able fit of the model, and values lower than 0.080 for the
RMSEA and SRMR indicate acceptable model fit [49]. The
strength of the standardized factor loadings between each
indicator and its corresponding latent variable were also
examined.
Invariance
The sex and longitudinal invariance of the best fitting DSS
model was tested in a multi-group CFA framework [35],
which consisted of testing different levels of invariance by
comparing nested models [31]. The first step involved
testing a baseline model (Model 1) with no constraints
that was estimated simultaneously across groups (i.e.,
across sex; across time whereby all three measurements
were entered into one model). This step serves to test the
weakest level of measurement invariance and represents
“configural invariance.” Invariance at this step would sug-
gest that the pattern of fixed and free factor loadings is in-
variant across groups. The second step involved adding
constraints on the factor loadings to be equal across
groups (Model 2). This is a stronger test of factorial invari-
ance and serves to test for “metric invariance” to ensure
that the expected change in the observed score on the
DSS per unit change on the latent variable is equal across
groups. The third step involved adding equality con-
straints on the item intercepts across groups and repre-
sents “scalar invariance” (Model 3). The fourth step
involved adding equality constraints on the uniquenesses
(i.e., disturbances) associated with the items across groups
(Model 4). This is a “strict” test of invariance and is akin
to testing invariance of the reliability associated with the
items if the latent factor variances are equal. Additional
tests of invariance were conducted by imposing equality
constraints across groups on factor variances (Model 5),
factor covariances (Model 6; only if the best fitting
model was the two- or three-factor model), and latent
factor means (Model 7) [31]. Invariance at each step
was established if a ΔCFI ≤ 0.010 was supplemented by
a ΔRMSEA ≤ 0.015 [48]a.
Predictive validity
To assess the final objective of this study (i.e., the predict-
ive validity of the best fitting model), correlations (Pearson
Table 1 Standardized factor loadings of the 6-items of the depressive symptoms scale
Single-factor model Two-factor model Three-factor model
Items I I II I II III
1. Felt too tired to do things .37/.63/.66 .54/.74/.81 .54/.74/.82
2. Had trouble going to sleep or staying asleep .35/.60/.57 .50/.70/.69 .51/.71/.70
3. Felt unhappy, sad, or depressed .62/.81/81 .62/.81/.81 .68/.87/.87
4. Felt hopeless about the future .60/.76/.71 .60/.77/.72 .66/.81/.75
5. Felt nervous or tense .58/.73/.82 .59/.73/.82 .70/.78/.84
6. Worried too much about things .74/.81/.86 .75/.81/.87 .81/.88/.90
Note. First, second, and third factor loadings correspond to Time 1, 2, and 3, respectively.
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scores obtained at Time 3 and depression and anxiety dis-
orders as assessed with the MDI and CIDI at Time 4.Results
Factor structure
The fit indices for all three CFA models are presented in
Table 2. The intercorrelated three-factor model provided a
better fit to the data at Time 1, 2, and 3 based on the stan-
dardized factor loadings (Table 1), and fit indices (Tables 1
and 2). The Cronbach’s alpha coefficients for this model
were > 0.70 at each time point, except for the somatic and
depressive symptoms factors at Time 1 (α ≥ 0.60). The scores
showed moderate stability across time (ICC: Time1-2: = 0.54;
Time2-3: = 0.77). Positive correlations of moderate to
high magnitude were observed between the latent fac-
tors at each time point: rsomatic, depression = 0.65, 0.76,
0.77; rsomatic, anxiety = 0.59, 0.78, 0.74; rdepression, anxiety =
0.81, 0.82, 0.88 at Time 1, 2, and 3, respectively.Table 2 Goodness of fit statistics for the measurement
models at each time point
Model χ2 df CFI |ΔCFI| RMSEA |ΔRMSEA| SRMR
Time 1
Single-factor 35.727 9 .965 - .075 - .041
Two-factors* 21.426 8 .982 .017 .057 .018 .028
Three-factors* 6.972 6 .999 .017 .018 .039 .016
Time 2
Single-factor 119.231 9 .953 - .153 - .049
Two-factors* 88.627 8 .967 .014 .138 .015 .036
Three-factors* 13.522 6 .997 .030 .049 .089 .017
Time 3Sex invariance
Table 3 displays the results of the invariance testing for
the intercorrelated three-factor model. It shows that the
configural, metric, and scalar invariance of the model
was supported, and that the factor variances and covari-
ances were invariant across sex at each time point based
on ΔCFI and ΔRMSEA values. However, the unique-
nesses (i.e., disturbances) associated with each item were
non-invariant at Time 3. In addition, the latent factor
means were non-invariant at Time 2 and 3, indicating
that there are significant differences across sexes at these
time points on the DSS subscale scores, with girls
reporting higher scores at both time point.Single-factor 107.229 9 .959 - .144 - .049
Two-factors* 55.790 8 .981 .022 .107 .037 .027
Three-factors* 13.490 6 .997 .016 .049 .058 .015
Note. χ2 = Chi-square; df = degrees of freedom; RMSEA = root mean square
error of approximation; CFI = confirmatory fit index; SRMR = standardized root
mean squared of the residuals.
*indicates statistically significant difference between nested models based on
ΔCFI > |.010| supplemented by a ΔRMSEA > |.015|.Longitudinal invariance
The configural, metric, and scalar invariance of the
model including measurements at all three time points
was also supported, as was the invariance of the item
uniquenesses, factor variances, covariances and means
based on ΔCFI and ΔRMSEA values (Table 4).Predictive validity
As reported in Table 5, Time 3 DSS subscales scores had
low to moderate correlations with depressive symptoms
and anxiety assessed at Time 4. Time 3 somatic symptoms
had a higher correlation with Time 4 somatic symptoms
than with the Time 4 affective/cognitive symptoms. In
contrast, Time 3 depressive symptoms and anxiety symp-
toms had higher correlations with Time 4 affective/cogni-
tive symptoms than with somatic symptoms.Discussion
The objectives of the current study were to test the under-
lying structure of the DSS in a non-clinical relatively large
sample of adolescents, evaluate sex and longitudinal in-
variance, and examine its predictive validity. The findings
support the hypothesis that the DSS can be conceptualized
as a multidimensional scale, and that it meets recom-
mended criteria to allow for accurate and meaningful
Table 3 Fit indices for the analyses testing sex invariance for the intercorrelated three-factor model
Model χ2 df CFI |ΔCFI| RMSEA |ΔRMSEA| SRMR
Time 1
Configural invariance 14.287 12 .997 - .027 - .025
Metric invariance 16.354 15 .998 .001 .019 .005 .030
Scalar invariance 26.507 18 .989 .009 .033 .017 .030
Invariant uniquenesses 28.011 24 .995 .006 .025 .008 .035
Invariant factor variances 35.900 27 .988 .003 .035 .010 .053
Invariant factor covariances 41.375 30 .984 .004 .038 .003 .053
Invariant latent means 49.462 33 .976 .008 .044 .006 .054
Time 2
Configural invariance 23.184 12 .995 - .059 - .016
Metric invariance 23.881 15 .995 0 .063 .004 .018
Scalar invariance 46.069 18 .986 .009 .077 .014 .032
Invariant uniquenesses 74.244 24 .972 .014 .089 .012 .044
Invariant factor variances 83.204 27 .970 .002 .089 0 .093
Invariant factor covariances 86.952 30 .969 .001 .085 .004 .088
Invariant latent means* 140.193 33 .940 .029 .111 .026 .096
Time 3
Configural invariance 15.308 12 .998 - .032 - .023
Metric invariance 15.716 15 1.00 .002 .018 .014 .023
Scalar invariance 23.941 18 .997 .003 .036 .018 .025
Invariant uniquenesses* 68.818 24 .977 .020 .084 .048 .059
Invariant factor variances 72.597 27 .977 0 .080 .004 .063
Invariant factor covariances 90.318 30 .969 .008 .088 .008 .070
Invariant latent means* 181.294 33 .923 .046 .131 .043 .067
Note. χ2 = Chi-square; df = degrees of freedom; RMSEA = root mean square error of approximation; CFI = confirmatory fit index; SRMR = standardized root mean
squared of the residuals.
*indicates statistically significant difference between nested models based on ΔCFI > |.010| supplemented by a ΔRMSEA > |.015|.
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scale scores on the DSS during late adolescence related to
depressive symptoms and anxiety disorders in early
adulthood.
Based on the current findings, the intercorrelated
three-factor model fit the data best. These results areTable 4 Fit indices for the analyses testing longitudinal invar
Model χ2 df CFI
Configural invariance 127.124 30 .982
Metric invariance 135.244 33 .980
Scalar invariance 191.889 42 .971
Invariant uniquenesses* 232.535 48 .978
Invariant factor variances 237.569 51 .963
Invariant factor covariances 246.727 54 .963
Invariant latent means 309.438 60 .954
Note. χ2 = Chi-square; df = degrees of freedom; RMSEA = root mean square error of a
squared of the residuals.
*indicates statistically significant difference between nested models based on ΔCFIsimilar to previous factor-analytic studies that report
multidimensional factor structures for other self-report
measures including the HADS [24,25], the BDI-II [26,27],
and the CES-D [28,29]. This provides support for the tri-
partite model [19] as well as previous research [50,51],
and suggests that the DSS can be used in research as aiance for the intercorrelated three-factor model
|ΔCFI| RMSEA |ΔRMSEA| SRMR
- .077 - .015
.002 .077 0 .031
.009 .082 .005 .033
.007 .084 .002 .042
.015 .083 .001 .107
0 .084 .001 .121
.009 .085 .001 .122
pproximation; CFI = confirmatory fit index; SRMR = standardized root mean
> |.010| supplemented by a ΔRMSEA > |.015|.
Table 5 Correlations between Time 3 depressive symptoms scale scores and Time 4 depression and anxiety disorders scores
MDI CIDI










Somatic symptoms .43** .43** .37** .28** .22** .16** .11* .21**
(.35-.50) (.35-.50) (.29-.45) (.19-.37) (.13-.31) (.07-.25) (.02-.20) (.12-.30)
Depressive symptoms .40** .32** .42** .26** .30** .19** .18** .26**
(.32-.48) (.23-.40) (.34-.50) (.17-.35) (.21-.38) (.10-.28) (.09-.27) (.17-.35)
Anxiety symptoms .37** .31** .37** .24** .37** .17** .16** .26**
(.29-.45) (.22-.39) (.29-.45) (.15-.33) (.29-.45) (.08-.26) (.07-.25) (.17-.35)
Note. Presence of anxiety was established if participants had at least one of the specific anxiety disorders.
*indicates significant associations at the p < .05 level.
**indicates significant associations at the p < .01 level.
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to general psychological distress including somatic, de-
pressive, and anxiety symptoms. This conclusion differs
from that of Kandel and Davies [6,13], who suggested that
the DSS is unidimensional. Nonetheless, these studies
differed in several important ways. First, NDIT was
conducted with a large non-clinical sample of adoles-
cents (n = 527), in contrast to the small clinical sample
of adolescents (n = 29) in the earlier study [6]. Second,
NDIT participants were asked to report symptoms in
the last 3 months, whereas participants in Kandel and
Davies’ [6,13] studies reported symptoms in the last
year. Third, NDIT participants completed the scale re-
peatedly over time, which may have increased familiar-
ity with the items in the scale and reduced unrelated
sources of test difficulty [52]. Increasing familiarity and
precision (as indicated by higher Cronbach’s coefficients
over time) may have resulted in improved differentiation
of the dimensions of distress in the current study. Fourth,
a 4-point response scale was used in the current study,
while a 3-point response scale was used in Kandel and
Davies’ [6,13] study. Last, the current study used analytic
techniques geared toward ordinal values, whereas Kandel
and Davies [6,13] treated the data as continuous despite
having a Likert scale with three response categories.
Therefore, additional research using CFA is needed to ver-
ify whether the current findings can be replicated in other
samples that vary in age, sample source (e.g., patients,
community sample), and frequency of administration.
The strong associations observed between the DSS sub-
scales are similar to those reported previously [17,51]. A
frequently cited reason for the high correlations is that the
etiologic origins of depression and anxiety are similar, and
that anxiety and depression may co-occur [16]. However,
this does not imply that these factors should be combined
in measurement tools, especially since these disorders may
have different determinants and/or outcomes, and theymay require different treatment strategies [53]. As
pointed out by Bollen and Hoyle [54], “high or even per-
fect correlations is not a sufficient condition to claim
that a concept is unidimensional” (p. 497). In fact, a
multidimensional conceptualization of the DSS may
have practical utility. It could help tailor interventions
when individuals have specific symptoms determined by
high scores on one subscale. It could also provide key
information when evaluating the effectiveness of inter-
ventions to reduce depressive, anxiety, and somatic
symptoms since researchers may find change in one di-
mension, but not the others. This information would be
masked if researchers used a combined score. Nonethe-
less, further work is required to increase the discriminant
validity of this scale and address its other potential short-
comings, most notably that there are only two items per
subscale. It is recommended that positive affectivity items
be added to the scale (see [55] for discussion) since de-
pression encompasses a combination of high negative
affectivity and low positive affectivity, while anxiety en-
compasses negative aspects of affectivity only [53]. These
additions may ensure that all dimensions are covered, and
increase the discriminant validity of the DSS.
The factor structure of the scale was invariant across sex
and time. These findings support previous research that
has shown that the meaning of items measuring depression
and anxiety is similar across age [28,29,56,57]. Further-
more, the findings of invariance indicate that meaningful
and interpretable comparisons of mean scores can be made
when using the DSS in a non-clinical sample of adoles-
cents. However, the item uniquenesses were non-invariant
across sex at Time 3, and while the item uniquenesses were
invariant across time, the reliability coefficients suggest that
the measurement errors associated with each item tended
to be larger at the beginning of the study. This may be a re-
sult of repeated exposure to the measures which increases
participants’ familiarity and reduces unrelated sources of
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research setting at baseline could have introduced height-
ened error, after which error could have decreased due to
familiarity with the test protocol. Further exploration into
these issues is needed. Nevertheless, it is important to note
that this level of invariance is referred to as “strict invari-
ance” and is believed to be difficult to achieve [59]. Further,
it is not a requirement to test for differences in factor
structure or latent means [59], and thus meaningful com-
parisons across sex and time can still be made when the
DSS is used.
Consistent with previous research using other measures
[3,4,13], individuals who scored higher on the DSS during
late adolescence were more likely to report depressive
symptoms in young adulthood, providing support for the
predictive validity of the DSS. In contrast, the predictive
validity of the DSS in regards to future anxiety disorders
was relatively weak. Longitudinal studies examining the
temporal relationships between depression and anxiety dis-
orders have reported conflicting results [4,60]. One study
with a community sample of youth found that depressive
symptoms did not predict anxiety 3 years later [37]. In con-
trast, Pine et al. [6] found that a history of MDD in adoles-
cence was significantly associated with an increase in risk
for developing generalized anxiety disorder in young adult-
hood. As such, future research should clarify whether the
onset of anxiety precedes the onset of depression, whether
the onset of depression precedes the onset of anxiety, or
whether there is a bi-directional association.
Limitations of this study include that only participants
with complete or minimal missing data were included.
While mean scores on the DSS were comparable for par-
ticipants retained and not retained for the analyses, and
were similar to levels reported in previous research [8],
participants retained for the analyses were marginally
younger than those not retained, and were more likely to
be English-speaking. Though it is unlikely, it is not pos-
sible to determine if these differences biased the results.
Also, although the models tested were based on theory
and empirical research [19,50,51], it is possible that alter-
native models whereby the items load on different latent
variables would adequately fit the data. Furthermore, each
latent variable in the three-factor model was identified by
only two indicators (i.e., items) when a minimum of three
indicators per latent variable is recommended [61]. In-
cluding additional items in each factor would likely im-
prove the reliability of the DSS and ensure that all
dimensions are fully covered. Therefore, there is potential
for scale improvement in future studies.
Conclusions
The current study is the first to test alternative factor
structures and the invariance of the DSS. The results en-
hance the utility of this brief scale by providingconfirmation that it can be conceptualized as multidi-
mensional with three related dimensions of distress (i.e.,
somatic, depressive, and anxiety symptoms). As such,
the appropriate model to use in future studies will re-
quire careful consideration of the research question. This
finding is timely in the context of the debate over the new
DSM-5 which proposes the addition of a mixed depression
and anxiety category. Further, both sex and longitudinal
invariance of the scale were confirmed, which suggests
that this scale may be used in research exploring sex dif-
ferences or the development of psychological distress
throughout adolescence. Accordingly, researchers seeking
a short, non-burdensome measure of depressive symp-
toms may use the DSS in their cross-sectional and longitu-
dinal studies to examine the links between the different
dimensions of distress captured by the DSS and a range of
psychological and physical health outcomes.
Endnote
aOther researchers have allowed residuals for all corre-
sponding observed variables to correlate across time points
to take into account the non-independence of observations
when examining longitudinal invariance. However, modifi-
cation indices did not suggest that estimating these resid-
uals in the models would improve model fit, meaning that
the residuals did not correlate with each other to a statisti-
cally significant degree across time. Thus, the residuals were
not allowed to correlate in the current study.
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